Search research articles
Contact Us
Filters
Showing results (531-540 of 632) with videos related to
Page
of 64
Sort By:
Journal of Internal Medicine
|
April 24, 2014
Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotirome
Bo Angelin, Jens D Kristensen, Mats Eriksson, et al.
The Neuroradiology Journal
|
February 28, 2025
Aristotle wires for cannulating target vessels in paediatric neuro-interventional procedures: A case-control study
K D Bhatia, T Blane, B Giarola, et al.
European Heart Journal. Acute Cardiovascular Care
|
October 18, 2024
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial
Philip Leissner, Katarina Mars, Sophia Humphries, et al.
Clinical Therapeutics
|
March 15, 2003
A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study
Anders G Olsson, Mats Eriksson, Owe Johnson, et al.
Journal of Chemical Information and Modeling
|
April 10, 2012
Potential and limitations of ensemble docking
Oliver Korb, Tjelvar S G Olsson, Simon J Bowden, et al.
The American Journal of Cardiology
|
February 25, 1993
The role of lipids and antioxidative factors for development of atherosclerosis. The Probucol Quantitative Regression Swedish Trial (PQRST)
G Walldius, J Regnström, J Nilsson, et al.
Journal of Internal Medicine
|
October 1, 1994
The relation of coronary and peripheral arterial disease to the severity of femoral atherosclerosis in hypercholesterolaemia
L Bergstrand, A G Olsson, U Erikson, et al.
JAMA
|
August 14, 2001
Atorvastatin for acute coronary syndromes
G G Schwartz, A G Olsson, M D Ezekowitz, et al.
European Heart Journal
|
March 16, 2005
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET
Karl Swedberg, Lars G Olsson, Andrew Charlesworth, et al.
The New England Journal of Medicine
|
March 12, 2010
Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia
Paul W Ladenson, Jens D Kristensen, E Chester Ridgway, et al.
Page
of 64
Search research articles
Search
Showing results (531-540 of 632) with videos related to
Sort By:
Page
of 64
Journal of Internal Medicine
|
April 24, 2014
Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotirome
Bo Angelin, Jens D Kristensen, Mats Eriksson, et al.
The Neuroradiology Journal
|
February 28, 2025
Aristotle wires for cannulating target vessels in paediatric neuro-interventional procedures: A case-control study
K D Bhatia, T Blane, B Giarola, et al.
European Heart Journal. Acute Cardiovascular Care
|
October 18, 2024
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial
Philip Leissner, Katarina Mars, Sophia Humphries, et al.
Clinical Therapeutics
|
March 15, 2003
A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study
Anders G Olsson, Mats Eriksson, Owe Johnson, et al.
Journal of Chemical Information and Modeling
|
April 10, 2012
Potential and limitations of ensemble docking
Oliver Korb, Tjelvar S G Olsson, Simon J Bowden, et al.
The American Journal of Cardiology
|
February 25, 1993
The role of lipids and antioxidative factors for development of atherosclerosis. The Probucol Quantitative Regression Swedish Trial (PQRST)
G Walldius, J Regnström, J Nilsson, et al.
Journal of Internal Medicine
|
October 1, 1994
The relation of coronary and peripheral arterial disease to the severity of femoral atherosclerosis in hypercholesterolaemia
L Bergstrand, A G Olsson, U Erikson, et al.
JAMA
|
August 14, 2001
Atorvastatin for acute coronary syndromes
G G Schwartz, A G Olsson, M D Ezekowitz, et al.
European Heart Journal
|
March 16, 2005
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET
Karl Swedberg, Lars G Olsson, Andrew Charlesworth, et al.
The New England Journal of Medicine
|
March 12, 2010
Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia
Paul W Ladenson, Jens D Kristensen, E Chester Ridgway, et al.
Page
of 64